Postnatal development of tyrosine-hydroxylase-immunoreactive cells in the rat retina. Morphology and distribution.

Dev Neurosci

Laboratoire de Neuro-Cytologie Oculaire, INSERM U 86, Paris, France.

Published: June 1989

The appearance and development of tyrosine-hydroxylase-immunoreactive cells were studied using whole mounts of postnatal rat retinas. The two classes of cells described in the adult retina were observed in the young rat. Small unipolar cells appeared as soon as the day of birth in the superior retina and large stellate cells by postnatal day (PND) 7. By PND 10, their number reached that of stellate cells of the adult-retina. It is hypothesized that small unipolar cells are transformed into large stellate cells as they mature. Several arguments are put forward to support this conclusion, the most important of which is the appearance of peripheral crescents containing a high density of small cells which disappear proportionately as the number of large stellate cells increases. The development of the vasculature was also studied. By PND 7, it was more developed in the temporal superior quadrant, in the region where the first stellate cells appeared.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000111881DOI Listing

Publication Analysis

Top Keywords

stellate cells
20
large stellate
12
cells
11
development tyrosine-hydroxylase-immunoreactive
8
tyrosine-hydroxylase-immunoreactive cells
8
small unipolar
8
unipolar cells
8
cells appeared
8
stellate
5
postnatal development
4

Similar Publications

Background: Calretinin is a 29 kilodalton (KDa) calcium-binding protein that is expressed in normal and tumoral tissues. The expression of calretinin has been shown in the dental epithelium during odontogenesis and in different odontogenic cysts and tumors such as ameloblastoma. Since the epithelium of calcifying odontogenic cyst (COC) is similar to ameloblastoma and in both lesions, an arrangement of loose cells similar to stellate reticulum is seen, we aimed to investigate the comparative expression of calretinin in COC and ameloblastoma.

View Article and Find Full Text PDF

Background: Cell therapy demonstrates promising potential as a substitute therapeutic approach for liver cirrhosis. We have developed a strategy to effectively expand murine and human hepatocyte-derived liver progenitor-like cells (HepLPCs) in vitro. The primary objective of the present study was to apply HepLPCs to the treatment of liver cirrhosis and to elucidate the underlying mechanisms responsible for their therapeutic efficacy.

View Article and Find Full Text PDF

Enhanced anti-inflammatory and anti-fibrotic effects of nanoparticles loaded with a combination of - extracts.

Mol Omics

January 2025

Departamento de Innovación Biomédica, Centro de Investigación Científica y de Educación Superior de Ensenada, Baja California (CICESE), Carretera Ensenada-Tijuana No. 3918, Zona Playitas, C.P. 22860, Ensenada, Baja California, Mexico.

Metabolic associated steatohepatitis characterized by lipid accumulation, inflammation and fibrosis, is a growing global health issue, contributing to severe liver-related mortality. With limited effective treatments available, there is an urgent need for novel therapeutic strategies. , rich in antioxidants, offers potential for combating steatohepatitis, but its cytotoxicity presents challenges.

View Article and Find Full Text PDF

Ginsenoside Rd (Rd) is a bioactive compound predominantly found in Panax ginseng C.A. Meyer and Panax notoginseng (Burkill) F.

View Article and Find Full Text PDF

m6A modified ATG9A is required in regulating autophagy to promote HSCs activation and liver fibrosis.

Cell Signal

January 2025

Department of Biochemistry and Molecular Biology, Shanxi Key Laboratory of Birth Defect and Cell Regeneration, MOE Key Laboratory of Coal Environmental Pathogenicity and Prevention, Shanxi Medical University, Taiyuan 030001, China. Electronic address:

Hepatic stellate cells (HSCs) are the central link of the occurrence and development of hepatic fibrosis, and autophagy promotes HSCs activation. N6-methyladenosine (m6A) RNA modification can also control autophagy by targeting selected autophagy-associated genes. but up to now, little research has been done on the m6A modification autophagy-related genes (ATGs) in hepatic fibrosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!